Cargando…
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis
BACKGROUND: Genetic and experimental studies support a causal involvement of interleukin-6 (IL-6) signaling in atheroprogression. While trials targeting IL-6 signaling are underway, any benefits must be balanced against an impaired host immune response. Dissecting the mechanisms that mediate the eff...
Autores principales: | Prapiadou, Savvina, Živković, Luka, Thorand, Barbara, George, Marc J., van der Laan, Sander W., Malik, Rainer, Herder, Christian, Koenig, Wolfgang, Ueland, Thor, Kleveland, Ola, Aukrust, Pal, Gullestad, Lars, Bernhagen, Jürgen, Pasterkamp, Gerard, Peters, Annette, Hingorani, Aroon D., Rosand, Jonathan, Dichgans, Martin, Anderson, Christopher D., Georgakis, Marios K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081435/ https://www.ncbi.nlm.nih.gov/pubmed/37034659 http://dx.doi.org/10.1101/2023.03.24.23287543 |
Ejemplares similares
-
Novel Insights Into the Effects of Interleukin 6 Antagonism in Non–ST‐Segment–Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform
por: George, Marc J., et al.
Publicado: (2020) -
Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction
por: Aukrust, Pål, et al.
Publicado: (2021) -
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
por: Ueland, Thor, et al.
Publicado: (2018) -
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021) -
Genetic and Genomic Epidemiology of Stroke in People of African Ancestry
por: Prapiadou, Savvina, et al.
Publicado: (2021)